|
ZNF678 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.361410E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77099999999686E-05 |
| Normal-vs-Stage2 |
1.009030E-01 |
| Normal-vs-Stage3 |
3.345600E-01 |
| Normal-vs-Stage4 |
2.227200E-01 |
| Stage1-vs-Stage2 |
5.017200E-01 |
| Stage1-vs-Stage3 |
1.002440E-01 |
| Stage1-vs-Stage4 |
6.229400E-01 |
| Stage2-vs-Stage3 |
5.796400E-01 |
| Stage2-vs-Stage4 |
9.916800E-01 |
| Stage3-vs-Stage4 |
6.545400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.359800E-04 |
| Normal-vs-AfricanAmerican |
6.10469999999808E-05 |
| Normal-vs-Asian |
1.115720E-02 |
| Caucasian-vs-AfricanAmerican |
2.601800E-01 |
| Caucasian-vs-Asian |
6.578800E-01 |
| AfricanAmerican-vs-Asian |
8.969200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08769999998637E-06 |
| Normal-vs-Female |
4.005800E-01 |
| Male-vs-Female |
2.424400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.651600E-02 |
| Normal-vs-Extreme_Weight |
1.11179999995326E-06 |
| Normal-vs-Obese |
7.537900E-02 |
| Normal-vs-Extreme_Obese |
2.178400E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.140850E-01 |
| Normal_Weight-vs-Obese |
6.379600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.476200E-02 |
| Extreme_Weight-vs-Obese |
1.750320E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.381000E-01 |
| Obese-vs-Extreme_Obese |
1.966140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.712400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.624800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.6628199999924E-05 |
| Normal-vs-Age(81-100Yrs) |
1.177940E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.598600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.043200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.920100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.534300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.124950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.753400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.52239999957105E-07 |
| Normal-VS-Type2 PRCC |
1.192160E-02 |
| Normal-VS-KIRP CIMP |
7.377800E-01 |
| Normal-VS-Unclassified PRCC |
7.941700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.658100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.563400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.967700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.055800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.048800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.738400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.779590E-04 |
| Normal-vs-N1 |
9.255000E-01 |
| Normal-vs-N2 |
1.384210E-02 |
| N0-vs-N1 |
3.688100E-02 |
| N0-vs-N2 |
7.242400E-01 |
| N1-vs-N2 |
2.499600E-01 |
|
|
